PT  - JOURNAL ARTICLE
AU  - Rurak, B.K.
AU  - Tan, J.
AU  - Rodrigues, J.P.
AU  - Power, B.D.
AU  - Drummond, P.D.
AU  - Vallence, A.M.
TI  - Cortico-cortical connectivity is influenced by levodopa in tremor-dominant Parkinson’s disease
AID  - 10.1101/2022.02.22.22270921
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2022.02.22.22270921
4099  - http://medrxiv.org/content/early/2024/02/06/2022.02.22.22270921.short
4100  - http://medrxiv.org/content/early/2024/02/06/2022.02.22.22270921.full
AB  - Background Resting tremor is the most common presenting motor symptom in Parkinson’s disease (PD). The supplementary motor area (SMA) is one of the main targets of the basal ganglia-thalamo-cortical circuit and has direct, facilitatory connections with the primary motor cortex (M1), which is important for the execution of voluntary movement. Dopamine potentially modulates SMA and M1 activity, and both regions have been implicated in resting tremor.Objective To examine SMA-M1 connectivity in individuals with PD ON and OFF dopamine medication, and whether SMA-M1 connectivity is implicated in resting tremor.Methods Dual-site transcranial magnetic stimulation was used to measure SMA-M1 facilitatory connectivity in PD participants ON and OFF levodopa. Resting tremor was measured using electromyography and accelerometry.Results Stimulating SMA had an inhibitory influence on M1 excitability OFF levodopa, and a facilitatory influence on M1 excitability ON levodopa. ON medication, correlational analysis showed an association between tremor severity and SMA-M1 connectivity, with SMA-M1 facilitation associated with smaller tremor than SMA-M1 inhibition.Conclusions The current findings contribute to our understanding of the neural networks involved in PD which are altered by levodopa medication and provide a neurophysiological basis for the development of interventions to treat resting tremor.Competing Interest StatementThe authors have declared no competing interest.Funding StatementB.K.R. was supported by an Australian Government Research Training Program scholarship and the Graduate Women (WA) Inc. Education Trust - Barbara Mary Hale Bursary. A.M.V. was supported by an Australian Research Council Discovery Early Career Researcher Award (DE190100694). Publication of this work was supported by the Bryant Stokes Neurological Research Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Murdoch University Human Research Ethics Committee (2018/117) gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yes